Omeprazol Almus (Omeprazole)

Omeprazol Almus is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining.
• Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.
• NSAID‑induced gastropathy: helps prevent ulcer formation in patients requiring long‑term NSAID therapy.

• Omeprazole selectively and irreversibly inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By blocking this final step of acid secretion, it markedly reduces both basal and stimulated gastric acid output, allowing mucosal healing and symptom relief in acid‑related disorders.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: gas‑related bloating.
• Constipation: infrequent.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis risk.
• Acute interstitial nephritis: kidney inflammation.
• Hypomagnesemia: low serum magnesium levels.
• Stevens‑Johnson syndrome: severe skin reactions.
• Fracture risk: potential decrease in bone mineral density with long‑term use.
• Liver enzyme elevation: abnormal hepatic function tests.

When using Omeprazol Almus, consider the following precautions:

• Assess renal function: adjust use in severe renal impairment.
• Evaluate hepatic status: use with caution if liver disease is present.
• Monitor long‑term therapy: periodic assessment for vitamin B12 deficiency and bone health.\n- Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Omeprazol Almus may interact with several medicines. Awareness of these interactions helps maintain therapeutic effectiveness.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet activity.
• Atorvastatin: increased plasma concentration.
• HIV protease inhibitors (e.g., ritonavir): decreased antiviral efficacy.

Moderate Interactions (Monitor Closely)

• Warfarin: potential alteration of INR values.
• Phenytoin: reduced serum levels.
• Methotrexate: increased exposure, especially at high doses.
• Digoxin: possible increase in serum concentration.
• Iron supplements: decreased absorption when taken simultaneously.